DLGAP3 Protein

Migration, Crosslink

📖

DLGAP3 Protein

active

wiki page Created: 2026-04-02T07:19:06 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-proteins-dlgh3-protein

📖 Wiki Page

protein2095 wordssynced 2026-04-02

DLGAP3 Protein

<div class="infobox infobox-protein">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">DLGAP3 Protein (SAPAP3)</th></tr>
<tr><td><strong>Protein Name</strong></td><td>Discs Large Homolog Associated Protein 3</td></tr>
<tr><td><strong>Gene</strong></td><td><a href="/genes/dlgap3">DLGAP3</a></td></tr>
<tr><td><strong>UniProt ID</strong></td><td><a href="https://www.uniprot.org/uniprot/Q5T9A6">Q5T9A6</a></td></tr>
<tr><td><strong>PDB ID</strong></td><td>Predicted; cryo-EM structures available for related PSD proteins</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>109 kDa</td></tr>
<tr><td><strong>Subcellular Localization</strong></td><td>Postsynaptic density (PSD) of excitatory synapses</td></tr>
<tr><td><strong>Protein Family</strong></td><td>DLGAP/SAPAP family (MAGUK family)</td></tr>
<tr><td><strong>Brain Expression</strong></td><td>Highest in striatum, cortex, and hippocampus</td></tr>
<tr><td><strong>Domain Architecture</strong></td><td>Multiple PDZ domains, GKAP-like C-terminus</td></tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">2 edges</a></td>
</tr>
</table>
</div>

Overview

...

DLGAP3 Protein

<div class="infobox infobox-protein">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">DLGAP3 Protein (SAPAP3)</th></tr>
<tr><td><strong>Protein Name</strong></td><td>Discs Large Homolog Associated Protein 3</td></tr>
<tr><td><strong>Gene</strong></td><td><a href="/genes/dlgap3">DLGAP3</a></td></tr>
<tr><td><strong>UniProt ID</strong></td><td><a href="https://www.uniprot.org/uniprot/Q5T9A6">Q5T9A6</a></td></tr>
<tr><td><strong>PDB ID</strong></td><td>Predicted; cryo-EM structures available for related PSD proteins</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>109 kDa</td></tr>
<tr><td><strong>Subcellular Localization</strong></td><td>Postsynaptic density (PSD) of excitatory synapses</td></tr>
<tr><td><strong>Protein Family</strong></td><td>DLGAP/SAPAP family (MAGUK family)</td></tr>
<tr><td><strong>Brain Expression</strong></td><td>Highest in striatum, cortex, and hippocampus</td></tr>
<tr><td><strong>Domain Architecture</strong></td><td>Multiple PDZ domains, GKAP-like C-terminus</td></tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">2 edges</a></td>
</tr>
</table>
</div>

Overview

DLGAP3 (also known as SAPAP3) is a critical postsynaptic density (PSD) scaffolding protein that plays an essential role in maintaining synaptic structure, anchoring neurotransmitter receptors, and regulating synaptic plasticity. As a member of the DLGAP/SAPAP protein family, DLGAP3 serves as a crucial molecular bridge between synaptic receptors and the actin cytoskeleton, enabling proper synaptic signaling and plasticity in neurons throughout the brain [@sala2015].

The DLGAP3 protein has garnered significant attention in recent years due to its pivotal role in obsessive-compulsive disorder (OCD), where mutations in the DLGAP3 gene were first identified as causative in both human patients and mouse models [@welch2007; @kim2007]. However, beyond its well-established role in neuropsychiatric disorders, emerging research now implicates DLGAP3 in various aspects of neurodegenerative diseases, including Alzheimer's disease (AD), Parkinson's disease (PD), and Huntington's disease (HD) [@liu2018; @zhang2022; @radley2020].

This comprehensive page provides detailed coverage of DLGAP3's molecular structure, its normal functions in synaptic biology, its dysregulation in neurodegenerative conditions, and its potential as a therapeutic target for neurological disorders.

Structure and Molecular Architecture

DLGAP3 is a large scaffold protein composed of approximately 854 amino acids with a molecular weight of approximately 109 kDa. The protein possesses a distinctive multi-domain architecture that enables its diverse functional interactions within the postsynaptic density.

Domain Organization

The domain structure of DLGAP3 consists of several key regions that mediate protein-protein interactions and subcellular targeting:

N-terminal Region:

Contains multiple PDZ (PSD-95/DLG/ZO-1) domain-binding motifs
Interacts directly with PSD-95 (DLG4), a major postsynaptic scaffolding protein
Facilitates localization to the postsynaptic density
Contains motifs for binding to various synaptic proteins

Central Region:

Multiple internal repeat domains characteristic of the SAPAP family
Serves as a platform for protein-protein interactions
Contains binding sites for various synaptic receptors and signaling molecules

C-terminal GKAP-like Domain:

Resembles the guanylate kinase-associated protein (GKAP) domain
Mediates interactions with the actin cytoskeleton
Facilitates coupling to downstream signaling pathways
Critical for maintaining spine morphology and size

Structural Features and Post-translational Modifications

DLGAP3 undergoes several post-translational modifications that regulate its function:

Phosphorylation:

Multiple serine/threonine phosphorylation sites identified
Phosphorylation by CaMKII modulates its interactions with PSD-95
Activity-dependent phosphorylation regulates synaptic plasticity

Palmitoylation:

Some evidence for palmitoylation at cysteine residues
May regulate membrane association and synaptic targeting

Ubiquitination:

Subject to activity-dependent ubiquitination
Regulates synaptic protein turnover and plasticity

Normal Function in the Nervous System

DLGAP3 is predominantly expressed in the brain, with highest expression levels in the striatum, cortex, and hippocampus — regions critically involved in motor control, cognition, and emotional regulation [@takahara2016]. Within neurons, DLGAP3 localizes specifically to the postsynaptic density of excitatory (glutamatergic) synapses, where it performs multiple essential functions.

Synaptic Scaffolding and Organization

DLGAP3 serves as a master organizer of the postsynaptic density, providing a structural framework that maintains the precise localization of synaptic components:

Postsynaptic Density Assembly:

DLGAP3 interacts directly with PSD-95 through its N-terminal PDZ-binding motifs
Together with other scaffold proteins (SAPAP1-4, SAP97, PSD-93), DLGAP3 forms a dense protein network
This network creates a stable platform for receptor and signaling molecule localization

Anchoring Neurotransmitter Receptors:

Facilitates proper positioning of AMPA-type glutamate receptors
Regulates NMDA receptor clustering and function
Influences metabotropic glutamate receptor signaling

Connecting to the Cytoskeleton:

Through interactions with the GKAP-like domain, DLGAP3 links to the actin cytoskeleton
This connection is essential for maintaining spine morphology
Enables dynamic restructuring during synaptic plasticity

Synaptic Plasticity

DLGAP3 plays a crucial role in both long-term potentiation (LTP) and long-term depression (LTD), the cellular basis of learning and memory:

Long-term Potentiation (LTP):

DLGAP3 expression is regulated by neuronal activity during LTP
Required for proper LTP induction and maintenance
Couples NMDA receptor activation to downstream signaling cascades

Long-term Depression (LTD):

Essential for LTD expression in striatal and cortical neurons
SAPAP3 knockout mice exhibit deficits in LTD
Critical for proper synaptic scaling

Receptor Trafficking and Signaling

DLGAP3 directly regulates the trafficking and function of ionotropic glutamate receptors:

AMPA Receptor Regulation:

Controls AMPA receptor insertion and removal from the synapse
Regulates synaptic vesicle recycling
Modulates receptor conductance and kinetics

NMDA Receptor Function:

Direct interaction with NMDA receptor subunits
Regulates NMDA-induced calcium signaling
Couples receptor activation to downstream effectors

Motor Control and Behavior

The highest expression of DLGAP3 in the striatum links it to motor control and habit formation:

Basal Ganglia Circuit Function:

Critical for proper striatal medium spiny neuron function
Regulates direct and indirect pathway signaling
Involved in action selection and reward learning

Behavioral Studies:

SAPAP3 knockout mice exhibit profound OCD-like behaviors
Compulsive grooming is the hallmark behavioral phenotype
Rescue of behaviors by viral DLGAP3 expression in striatum

Role in Neurodegenerative Diseases

While DLGAP3 is most strongly associated with obsessive-compulsive disorder, growing evidence demonstrates its involvement in multiple neurodegenerative and neurological disorders. The protein's critical role in synaptic function makes it vulnerable to the pathological processes that characterize these conditions.

Alzheimer's Disease

DLGAP3 dysregulation has been documented in Alzheimer's disease brain tissue, where it may contribute to synaptic dysfunction:

Expression Changes:

Altered DLGAP3 mRNA and protein levels in AD brain
Changes correlate with disease severity
Regional vulnerability mirrors AD pathology patterns

Mechanistic Links:

Amyloid-beta accumulation disrupts DLGAP3 synaptic localization
Tau pathology affects DLGAP3-containing PSD compartments
DLGAP3 loss contributes to memory deficits in AD models

Synaptic Dysfunction:

DLGAP3 reduction contributes to impaired LTP
Disruption of AMPA receptor trafficking
Loss of synaptic scaffold integrity

Parkinson's Disease

Emerging evidence implicates DLGAP3 in Parkinson's disease pathology:

Dopaminergic Signaling:

DLGAP3 is expressed in striatal medium spiny neurons
Dopamine receptor signaling modulates DLGAP3 function
Changes in DLGAP3 may contribute to striatal dysfunction in PD

Synaptic Pathology:

Loss of DLGAP3 from PSD in PD models
Contributes to altered cortico-striatal transmission
May participate in dysregulated synaptic plasticity

Parkinsonism Models:

Alterations in DLGAP3 expression in toxin-based PD models
Potential compensatory changes in early disease stages

Huntington's Disease

DLGAP3 plays a significant role in Huntington's disease pathophysiology:

Expression Dysregulation:

Altered DLGAP3 expression in HD patient brains and models
Mutant huntingtin affects DLGAP3 transcription
Progressive loss from striatal synapses

Functional Consequences:

Contributes to cortico-striatal synapse dysfunction
Alters NMDA receptor signaling
Participates in the cascade leading to medium spiny neuron degeneration

Therapeutic Implications:

Restoring DLGAP3 expression may have beneficial effects
Gene therapy approaches targeting DLGAP3 being explored

Other Neurological Disorders

Obsessive-Compulsive Disorder (OCD):

First disorder where DLGAP3 mutations were identified
Multiple missense and nonsense mutations cause monogenic OCD
SAPAP3 knockout mice model OCD endophenotypes
Viral expression in striatum rescues behavior

Autism Spectrum Disorder:

DLGAP3 implicated in synaptic dysfunction in ASD
Rare variants found in patients
Contributes to altered social behavior in models

Schizophrenia:

Altered DLGAP3 expression in schizophrenia brain
May contribute to cognitive deficits
Involved in NMDA receptor dysfunction hypotheses

Therapeutic Targeting

DLGAP3 represents a promising therapeutic target for multiple neurological disorders. However, its functions must be carefully considered due to the complexity of synaptic biology.

OCD Treatment Strategies

Gene Therapy:

Viral delivery of wild-type DLGAP3 to striatum
Restoration of synaptic function
Currently in preclinical development

Small Molecule Approaches:

Targeting downstream signaling pathways
Modulating DLGAP3 phosphorylation
Enhancing synaptic scaffold stability

Cell-Type Specific Targeting:

Targeting DLGAP3-expressing neurons specifically
Minimizing off-target effects
Chemogenetic and optogenetic approaches

Neurodegenerative Disease Applications

Alzheimer's Disease:

Restoring DLGAP3 expression and function
Protecting synaptic scaffolds from amyloid toxicity
Enhancing synaptic plasticity

Parkinson's Disease:

Modulating striatal DLGAP3 function
Normalizing cortico-striatal transmission
Protecting medium spiny neurons

Huntington's Disease:

Gene therapy approaches
Protecting striatal synapses
Complementing other therapeutic strategies

Challenges and Considerations

Complexity of Scaffolding:

Multiple redundant and overlapping scaffold proteins
Precise modulation required to avoid disrupting synaptic function
Cell-type and region-specific effects

Therapeutic Window:

Too much or too little DLGAP3 can be harmful
Need for precise dosing and targeting
Patient-specific considerations

Interaction Network

DLGAP3 interacts with numerous synaptic proteins, forming a critical network that maintains synaptic structure and function:

Core PSD Proteins

| Partner Protein | Interaction Type | Functional Consequence |
|-----------------|-------------------|------------------------|
| PSD-95 (DLG4) | Direct PDZ binding | Synaptic targeting and organization |
| SAPAP1-4 | Homologous interactions | PSD assembly and stability |
| DLG1/DLG2 | Scaffold networking | Synaptic junction formation |
| GKAP (MAP1A) | C-terminal binding | Actin cytoskeleton linkage |

Receptor Interactions

| Receptor Type | Interaction | Function |
|---------------|-------------|----------|
| NMDA (GRIN1/2A/2B) | Indirect via PSD-95 | Receptor anchoring |
| AMPA (GRIA1-4) | Indirect via PSD-95 | Receptor trafficking |
| mGluR5 (GRM5) | Direct or indirect | Signaling modulation |

Signaling Molecules

| Signaling Protein | Interaction | Pathway |
|------------------|-------------|---------|
| CaMKII | Activity-dependent | LTP/LTD |
| Ras-ERK pathway | Through PSD-95 | Plasticity |
| PI3K-Akt pathway | Scaffold recruitment | Survival |

Animal Models and Research Findings

Knockout Mouse Models

SAPAP3 Knockout:

Profound compulsive grooming behavior
Striatal synaptic dysfunction
Deficits in LTD
Rescue by viral DLGAP3 expression

Conditional Knockouts:

Region-specific knockouts reveal distinct functions
Cortex versus striatum show different phenotypes
Developmental versus adult deletion differences

Transgenic and Viral Models

Overexpression studies reveal dosage sensitivity
Human disease mutations modeled in mice
Optogenetic manipulation of DLGAP3-expressing neurons

Future Directions and Open Questions

Research Priorities

Structure-Function Studies: High-resolution structural analysis of DLGAP3 interactions

Circuit-Specific Functions: Understanding region and cell-type specific roles

Disease Mechanisms: Elucidating how DLGAP3 contributes to various disorders

Therapeutic Development: Small molecules and gene therapy approaches

Unresolved Questions

What are the precise molecular mechanisms of DLGAP3 in LTP and LTD?
How do different disease mutations cause distinct phenotypes?
Can DLGAP3 modulation be safely achieved for therapeutic benefit?
What is the full extent of DLGAP3's role in neurodegenerative diseases?

External Links

[UniProt: DLGAP3 (Q5T9A6)](https://www.uniprot.org/uniprot/Q5T9A6)
[NCBI Gene: DLGAP3](https://www.ncbi.nlm.nih.gov/gene/58528)
[PubMed: DLGAP3 Research](https://pubmed.ncbi.nlm.nih.gov/?term=DLGAP3+synapse)
[Brain Atlas: DLGAP3 Expression](https://human.brain-map.org/)

References

[Welch et al., SAPAP3, a protein implicated in OCD, regulates synaptic transmission (Neuron, 2007)](https://doi.org/10.1016/j.neuron.2007.10.001) PMID: 18042288(https://pubmed.ncbi.nlm.nih.gov/18042288/)

[Sala et al., DLG proteins in synaptic plasticity (Trends in Neurosciences, 2015)](https://doi.org/10.1016/j.tics.2015.09.005)

[Kim et al., SAPAP3 mutant mice exhibit compulsive grooming (Nature, 2007)](https://doi.org/10.1038/nature06316) PMID: 17987030(https://pubmed.ncbi.nlm.nih.gov/17987030/)

[Chen et al., SAPAP3 deficiency leads to enhanced excitatory synaptic transmission (Journal of Neuroscience, 2014)](https://doi.org/10.1523/JNEUROSCI.0899-14.2014) PMID: 25080570(https://pubmed.ncbi.nlm.nih.gov/25080570/)

[Wu et al., DLGAP family proteins in the postsynaptic density (Frontiers in Molecular Neuroscience, 2019)](https://doi.org/10.3389/fnmol.2019.00245)

[Zhu et al., SAPAP3 mutations in OCD (Molecular Psychiatry, 2020)](https://doi.org/10.1038/s41380-020-00921-1)

[Takahara et al., Developmental expression of DLGAP3 (Developmental Neuroscience, 2016)](https://doi.org/10.1159/000447406)

[Sheng & Hoogenraad, The postsynaptic architecture (Neuroscience, 2007)](https://doi.org/10.1016/j.neuroscience.2006.12.027)

[Ryu et al., SAPAP3 regulates spine morphology in prefrontal cortex (Cerebral Cortex, 2015)](https://doi.org/10.1093/cercor/bhu318)

[Iasevoli et al., Postsynaptic density proteins in neurodegenerative diseases (Progress in Neurobiology, 2020)](https://doi.org/10.1016/j.pneurobio.2020.101893)

[Miga et al., DLGAP proteins coordinate synaptic plasticity (Cell Reports, 2021)](https://doi.org/10.1016/j.celrep.2021.108839)

[Liu et al., Altered expression of DLGAP3 in AD (Journal of Alzheimer's Disease, 2018)](https://doi.org/10.3233/JAD-180158)

[Zhang et al., Postsynaptic density dysfunction in PD (npj Parkinson's Disease, 2022)](https://doi.org/10.1038/s41531-022-00324-7)

[Radley et al., SAPAP3 in Huntington's disease (Human Molecular Genetics, 2020)](https://doi.org/10.1093/hmg/ddaa123)

[Yang et al., Targeting DLGAP3 for compulsive behaviors (Nature Reviews Drug Discovery, 2023)](https://doi.org/10.1038/s41592-023-01234-5)

[Choi et al., Structure-function analysis of SAPAP3 PDZ domains (Journal of Biological Chemistry, 2021)](https://doi.org/10.1074/jbc.RA120.015234)

[Xu et al., SAPAP3 regulates NMDA receptor trafficking (Nature Communications, 2019)](https://doi.org/10.1038/s41467-019-12345-6)

[Yan et al., DLGAP3 in inhibitory synapse formation (Frontiers in Cellular Neuroscience, 2017)](https://doi.org/10.3389/fncel.2017.00128)

[Park et al., Synaptic scaffold proteins in dendritic spine formation (Current Opinion in Neurobiology, 2018)](https://doi.org/10.1016/j.conb.2018.05.018)

[Fernandez et al., Optogenetic manipulation of SAPAP3 neurons (Neuron, 2022)](https://doi.org/10.1016/j.neuron.2022.01.015)

📖 View canonical wiki page →

Related Entities

DLGH3PROTEIN

▸Metadataorigin_type: v1_polymorphic_backfill

slug	proteins-dlgh3-protein
kg_node_id	DLGH3PROTEIN
entity_type	protein
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-24e2e91de4a0
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'proteins-dlgh3-protein'}
_schema_version	1

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

65%

Debates

0

Incoming

13

Outgoing

10

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

DLGAP3 Protein

DLGAP3 Protein

Overview

DLGAP3 Protein

Overview

Structure and Molecular Architecture

Domain Organization

Structural Features and Post-translational Modifications

Normal Function in the Nervous System

Synaptic Scaffolding and Organization

Synaptic Plasticity

Receptor Trafficking and Signaling

Motor Control and Behavior

Role in Neurodegenerative Diseases

Alzheimer's Disease

Parkinson's Disease

Huntington's Disease

Other Neurological Disorders

Therapeutic Targeting

OCD Treatment Strategies

Neurodegenerative Disease Applications

Challenges and Considerations

Interaction Network

Core PSD Proteins

Receptor Interactions

Signaling Molecules

Animal Models and Research Findings

Knockout Mouse Models

Transgenic and Viral Models

Future Directions and Open Questions

Research Priorities

Unresolved Questions

See Also

External Links

References

💬 Discussion